KJ

Kanthi Jayalakshmi Appannagari

Active Director Designated Partner DIN 07108770
DIN 07108770 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kanthi Jayalakshmi Appannagari

Data last updated:

Kanthi Jayalakshmi Appannagari is a Designated Partner at Empyrean Hospitals Llp (since 2026).

DIN 07108770
Primary Designation Designated Partner
First Appointment 30 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner30 Jul 20262026Active

Board colleagues of Kanthi Jayalakshmi Appannagari

NameDINCompanyDesignation
Gudimetla Vikramaditya Reddy11530252Empyrean Hospitals LlpDesignated Partner
Uma Maheshwar Kodide11530253Empyrean Hospitals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Empyrean Hospitals Llp
Premium access

Shareholding and investment profile for Kanthi Jayalakshmi Appannagari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanthi Jayalakshmi Appannagari

Kanthi Jayalakshmi Appannagari currently holds 1 directorship: Empyrean Hospitals Llp (Designated Partner, since 30 Jul 2026).

Kanthi Jayalakshmi Appannagari was first appointed on 30 Jul 2026 as Designated Partner at Empyrean Hospitals Llp.

The current boards of Kanthi Jayalakshmi Appannagari's companies include Gudimetla Vikramaditya Reddy (Empyrean Hospitals Llp), Uma Maheshwar Kodide (Empyrean Hospitals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available